InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Hirofumi Imai, Executive. Officer active across 1 company, notably 富士製薬工業株式会社. In total, 5 disclosures have been logged. History available since 13 February 2023. The latest transaction was filed on 22 June 2026 (Holding update). Regulator: EDINET (Japan FSA). All data is openly available.
5 of 5 declarations
Hirofumi Imai is a significant shareholder of 富士製薬工業株式会社. As a shareholder, he plays a key role in the strategic direction of the company, ensuring that decisions made align with shareholder objectives.